LSP portfolio
LSP has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is eTheRNA Immunotherapies's $38.41M Series B+ round in June 2020, alongside Yijing Capital, Fund+, Boehringer Ingelheim Venture Fund and 5 others. That company is in Health and bio.
What LSP invests in
- Health and bio · 1 · 100%
How LSP invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $38.41M |
LSP portfolio companies
EeTheRNA Immunotherapies$38.41MSeries B+ · Jun 2020
| Company | Round with LSP | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $38.41M | $104.41M | Aug 24, 2022 Series B+ |
Most frequent co-investors
PPMV1 shared round · last Jun 16, 2020
OOmega Funds1 shared round · last Jun 16, 2020
BBoehringer Ingelheim Venture Fund1 shared round · last Jun 16, 2020
CChina Grand Pharmaceutical and Healthcare Holdings1 shared round · last Jun 16, 2020
FFund+1 shared round · last Jun 16, 2020
NNovalis LifeSciences1 shared round · last Jun 16, 2020
BBNP Paribas Private Equity1 shared round · last Jun 16, 2020
YYijing Capital1 shared round · last Jun 16, 2020
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name LSP. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists LSP, which is a subset of its real portfolio. API: /api/v1/investors/lsp (get a free API key). More: the most active VC firms and new venture capital funds.